Hansa Biopharma AB (publ) (HNSBF) Q2 2025 Earnings Call Transcript

2025-07-17 10:46:16 ET

Hansa Biopharma AB (publ) (HNSBF)

Q2 2025 Earnings Conference Call

July 17, 2025, 8:00 AM ET

Company Participants

C. Evan Ballantyne - CFO & Senior VP

Hitto Kaufmann - Senior VP, Chief R&D Officer

Monika Tornsen - COO & President of U.S.

Renee Aguiar-Lucander - Chief Executive Officer

Conference Call Participants

Douglas Dylan Tsao - H.C. Wainwright & Co, LLC, Research Division

Matthew Christopher Phipps - William Blair & Company L.L.C., Research Division

Sushila Hernandez - Unidentified Company

Presentation

Operator

Good day, and welcome to the Hansa Biopharma Second Quarter Earnings Conference Call. [Operator Instructions]. Please note today's event is being recorded. I would now like to turn the conference over to Renee Aguiar-Lucander, Chief Executive Officer. Please go ahead.

Renee Aguiar-Lucander

Thank you. Good afternoon, and good morning, everyone, and welcome to the Hansa Biopharma Conference Call to review Q2 and half year results for 2025. I'm Renee Aguiar-Lucander, CEO of Hansa Biopharma....

Read the full article on Seeking Alpha

For further details see: